Indivior profit slumps on legal costs, higher litigation provisions

(Reuters) - British drugmaker Indivior on Thursday reported a steep fall in first-quarter profit, as it spent heavily on promoting its newer opioid treatment and incurred higher costs related a U.S. investigation into its best-selling drug.The company, which withdrew its 2020 forecast last month over uncertainty related to the coronavirus crisis, said adjusted operating profit in three months to March fell to $3 million(2.46 million pounds) from $102 million a year ago...